Veracyte Inc (NASDAQ:VCYT) traded at $30.38 at close of the session on Monday, March 10 and made a downward move of -5.12% on its previous day’s price.
Veracyte Inc has a market cap of $2.37 billion and is expected to release its quarterly earnings report in April.
Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at 110.54M, with a low of 104M and a high of 118.3M. The median projection represents growth squeezing down to 14.14% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for current year is expected to hit 487.59M, or 9.38% up from figures reported last year.
On the other hand, looking at the outlook for the VCYT stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 50% Buy.
Looking further, we note that the PEG ratio for the VCYT stock currently stands at 1.85, and the current price level is -17.81% off its SMA20 and -24.73% from its 50-day simple moving average. The RSI (14) is pointing at 29.01 while the volatility over the past week is 6.39% and jumps to 6.41% over the past one month. The beta value is 2.03, while the average true range (ATR) is currently pointing at 2.25. The average price target for the stock over the next 12 months is $44, with the estimates having a low of $44 and a high of $44. These price ends are -44.83% and -44.83% off the current price level respectively, although investors could be excited at the prospect of a -44.83% if the VCYT share price touches on the median price of $44.
